Artificial Skin
Latin America · 1 shared keyword
Updated
Reviewed by Vidhi Upadhyay
Latin America Bacteriophage Therapy Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$9.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $3.0 Mn | — | — |
| 2025 (base) | $3.5 Mn | +$0.5 Mn | — |
| 2026 (forecast) | $4.0 Mn | +$0.5 Mn | +15.7% |
| 2027 (forecast) | $4.7 Mn | +$0.6 Mn | +33.9% |
| 2028 (forecast) | $5.4 Mn | +$0.7 Mn | +54.9% |
| 2029 (forecast) | $6.2 Mn | +$0.8 Mn | +79.2% |
| 2030 (forecast) | $7.2 Mn | +$1.0 Mn | +107.3% |
| 2031 (forecast) | $8.3 Mn | +$1.1 Mn | +139.9% |
| 2032 (forecast) | $9.7 Mn | +$1.3 Mn | +177.5% |
| 2033 (forecast) | $11.2 Mn | +$1.5 Mn | +221.1% |
| 2034 (forecast) | $12.9 Mn | +$1.8 Mn | +271.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $3.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $12.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 15.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type, application and end user (see all) |
| Key players | Armata Pharmaceuticals, Locus Biosciences, Adaptive Phage Therapeutics, BiomX, Intralytix (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Bacteriophage therapy uses viruses that infect only bacteria to treat infections that antibiotics cannot clear.
Key segments of the bacteriophage Therapy market include type (Natural Phages, Engineered Phages and Phage Cocktails) and application (Chronic Wounds, Respiratory Infections and Urinary Infections).
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the bacteriophage Therapy market.
New vaccines, rapid tests and public-private funding for neglected diseases give the bacteriophage Therapy market room to grow, especially in Asia, Africa and Latin America.
Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the bacteriophage Therapy market.
The bacteriophage Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medicines are approved by ANVISA (Brazil)[1], ARCSA (Ecuador)[2] and COFEPRIS (Mexico)[3]. How care is paid for in some of these countries: the SUS (Brazil)[4]; public care and IESS (Ecuador)[5]; and IMSS, ISSSTE and IMSS-Bienestar (Mexico)[6].
[1] ANVISA. Checked 14 Nov 2026.
[2] ARCSA. Checked 14 Nov 2026.
[3] COFEPRIS. Checked 14 Nov 2026.
[4] CONITEC. Checked 14 Nov 2026.
[5] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.
[6] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for bacteriophage Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Latin America.
What doctors and scientists are doing in Bacteriophage Therapy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Latin America · 1 shared keyword
Latin America
Latin America
Latin America
Latin America
Latin America
Medical Devices · Latin America
Medical Devices · Latin America
OTC & Nutraceuticals · Latin America
OTC & Nutraceuticals · Latin America
Medical Devices · Latin America
Healthcare Services · Latin America